Landsberg Bennett & Dubbaneh’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-24,680	Closed	-$3K	–	247
2018 Q4	$3K	Buy	+24,680	New	+$16.2K	﹤0.01%	191

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's SGYP Position: Q1 2019 in Review

Landsberg Bennett & Dubbaneh sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 24,680 shares — an estimated $3K sold.

Landsberg Bennett & Dubbaneh first reported a position in SGYP in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Landsberg Bennett & Dubbaneh reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Landsberg Bennett & Dubbaneh sold 24,680 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $3K.
Landsberg Bennett & Dubbaneh first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2018 and held it in 1 quarter.
Landsberg Bennett & Dubbaneh's Synergy Pharmaceuticals, Inc Common Stock position peaked at $3K in Q4 2018.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q1 2019, filed 12 Apr 2019.